A phase 0 study of dasatinib in endometrial cancer von Lothamer, H, Faust, W, Petroni, G, Fracasso, P.M, Parsons, S

Volltext

A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab, and veliparib (ABT-888) in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallop... von Brady, W.E, Armstrong, D.K, Moore, K.N, DiSilvestro, P.A, O'Malley, D.M, Tenney, M.E, Rose, P.G, Fracasso, P.M

Volltext

A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852) von Thaker, P.H., Salani, R., Brady, W.E., Lankes, H.A., Cohn, D.E., Mutch, D.G., Mannel, R.S., Bell-McGuinn, K.M., Di Silvestro, P.A., Jelovac, D., Carter, J.S., Duan, W., Resnick, K.E., Dizon, D.S., Aghajanian, C., Fracasso, P.M.

Volltext

Tolerability and adverse events experienced by women with ovarian cancer treated with intravenous or intraperitoneal chemotherapy plus veliparib and bevacizumab based on BRCA statu... von Gillen, J., Miller, A., Moore, K.N., Bell-McGuinn, K.M., Schilder, R., Walker, J.L., Brady, W.E., O'Cearbhaill, R.E., Guntupalli, S.R., Armstrong, D.K., Hagemann, A.R., Gray, H.J., Duska, L.R., Mathews, C.A., Chen, A., O'Malley, D.M., Gordon, S.W., Fracasso, P.M., Aghajanian, C.

Volltext

A phase 1/2 trial of a monoclonal antibody targeting fucosyl GM1 in relapsed/refractory small cell lung cancer (SCLC): Safety and preliminary efficacy von Chu, Q.S.-C., Markman, B., Leighl, N., Krug, L., Rudin, C., Lathers, D., Basciano, P., Fracasso, P.M., Kollia, G., Phillips, P., Kolaitis, G., Williams, D., Jackson, J., Ready, N.

Volltext

A phase 2, fast real-time assessment of combination therapies in immuno-oncology trial in patients with advanced non-small cell lung cancer (FRACTION-lung) von Fracasso, P.M., Freeman, D.J., Simonsen, K., Shen, Y., Gupta, M., Comprelli, A., Gainor, J.F., Hellmann, M., Chow, L.Q., Forde, P.M., Govindan, R., Reilly, T.P., Cassidy, J.

Volltext

Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies von Tan, B.R., Brenner, W.S., Picus, J., Marsh, S., Gao, F., Fournier, C., Fracasso, P.M., James, J., Yen-Revollo, J.L., Mcleod, H.L.

Volltext

Phase I study of rubitecan and gemcitabine in patients with advanced malignancies von Fracasso, P. M., Rader, J. S., Govindan, R., Herzog, T. J., Arquette, M. A., Denes, A., Mutch, D. G., Picus, J., Tan, B. R., Fears, C. L., Goodner, S. A., Sun, S. L.

Volltext

Evaluation of some biological parameters for the early diagnosis of cancer of the large intestine von Casale, V., Fracasso, P., Casole, P.M., Cianciulli, A., Greco, C., De Frenceschi, L., Gandolfo, G.M., Grassi, A., Lapenta, R., Stigliano, V.

Volltext